MedTrace Logo

Prognostic Value of P30 After Cardiac Arrest

NCT03175965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2019-05-14

No results posted yet for this study

Summary

This study aims to examine whether P30 wave of somatosensory evoked potentials (SEP) is related with outcome after cardiac arrest. The study design is a prospective, multicenter-observational study. Patients survived after out-of-hospital cardiac arrest undergoing hypothermic-targeted temperature management will participate in the study. Relationship of P30 wave of SEP with the neurologic outcome on hospital discharge will be evaluated.

Conditions

  • Out-Of-Hospital Cardiac Arrest

Interventions

DEVICE

Somatosensory evoked potential

Somatosensory evoked potential on 24, 72 hours after cardiac arrest.

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Uijeongbu St. Mary Hospital

    lead OTHER

Principal Investigators

  • Joo Suk Oh, MD · Uijeongbu St. Mary's Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-11-30
Completion
2018-11-30
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03175965 on ClinicalTrials.gov